Article in African newspaper on treatments for COVID-19 mentions that organizations such as ISMP and the Food and Drug Administration (FDA) in the U.S. are constantly monitoring drug safety issues and have provided healthcare consumers with information on COVID-19.
For the full text, visit The Nambian online.
More News
ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.
This video appeared on the Pharmacy Times website on June 18, 2020.
Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol product that has double the concentration of what is available in the U.S.